北米整形外科インプラント（歯科インプラントを含む）市場
Market Size in USD Billion
CAGR :
% 
 予測期間 |
2024 –2030 |
 市場規模（基準年） |
|
 Market Size (Forecast Year) |
USD 51,373.73 |
 CAGR |
% |
| 主要市場プレーヤー |
>北米整形外科インプラント（歯科インプラントを含む）市場、製品タイプ別（再建関節置換術、脊椎インプラント、運動保存デバイス/非融合デバイス、歯科インプラント、外傷インプラント、整形生物学、その他）、生体材料（金属生体材料、セラミック生体材料、ポリマー生体材料、天然生体材料、その他）、手順（開腹手術、低侵襲手術（MIS）、その他）、固定タイプ（セメント整形外科インプラント、セメントレス整形外科インプラント、ハイブリッド整形外科インプラント）、エンドユーザー（病院、診療所、外来手術センター、在宅ケア環境、学術研究機関、その他）、流通チャネル（直接入札、小売販売、その他）業界動向と2030年までの予測。
北米整形外科インプラント（歯科インプラントを含む）市場分析と洞察
整形外科用インプラントは、硬組織用途で骨や関節を置き換えるために使用される材料です。このカテゴリには、骨折を安定させるために埋め込まれる固定プレートも含まれます。世界の高齢者人口が非常に多いため、骨の損傷や骨折の数は近年増加しています。骨粗鬆症と変形性関節症は、最近、高齢者の最も一般的な病気の 1 つになっています。高齢者のその他の局所的な転倒傷害の頻度も、市場の成長の原動力であることが証明されています。さらに、ロボット手術装置、整形外科用インプラントや埋め込み型医療機器の急速な導入、整形外科の問題を治療するための他の多くの最新技術などの技術の進歩と革新が、予測期間中に市場を活性化させました。
Data Bridge Market Research の分析によると、北米の整形外科用インプラント (歯科用インプラントを含む) 市場は、予測期間中に 13.9% の CAGR で成長し、2030 年までに 513 億 7,373 万米ドルに達する見込みです。北米では整形外科用インプラントの需要が急増しているため、この製品タイプが市場で最大のセグメントを占めています。この市場レポートでは、価格分析、特許分析、技術進歩についても詳細に取り上げています。
|
レポートメトリック |
詳細 |
|
予測期間 |
2023年から2030年 |
|
基準年 |
2022 |
|
歴史的な年 |
2021 (2020 - 2016 にカスタマイズ可能) |
|
定量単位 |
売上高（百万米ドル）、販売数量（個数）、価格（米ドル） |
|
対象セグメント |
By Product Type (Reconstructive Joint Replacements, Spinal Implants, Motion Preservation Devices/Non-Fusion Devices, Dental Implants, Trauma Implants, Orthobiologics, and Others), Biomaterial (Metallic Biomaterials, Ceramic Biomaterial, Polymeric Biomaterials, Natural Biomaterials, and Others), Procedures (Open Surgery, Minimally Invasive Surgery (MIS), and Others), Fixation Type (Cement Orthopedic Implants, Cementless Orthopedic Implants, and Hybrid Orthopedic Implants), End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, Academic and Research Institutes, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others). |
|
Countries Covered |
U.S., Canada, and Mexico. |
|
Market Players Covered |
DePuy Synthes (a Subsidiary of Johnson & Johnson Inc.), Zimmer Biomet, Smith & Nephew plc, Medtronic, Stryker, B. Braun Melsungen AG, Changzhou Waston Medical Appliance Co., Ltd., Integra LifeSciences, Narang Medical Limited, W.L. Gore & Associates, Inc., 3M, Arthrex, Inc., General Electric Company, DJO, LLC (a Subsidiary of Colfax Corporation), Samay Surgical, BioHorizons, Envista, Egifix, Institut Straumann AG, Canwell Medical Co., Ltd., Corin Group, Globus Medical, CONMED Corporation, Bonetech Medisys P.V.T LTD., and EgiFix Medical among others. |
Market Definition
Orthopedic implants are classified into two groups, including permanent joint replacements and temporary fracture fixation devices. Orthopedic implants include hip, knee, ankle, shoulder, elbow, wrist, and finger joints that should serve the human body throughout the patient's life. On the other hand, temporary orthopedic implants such as plates, screws, pins, wires, and intramedullary nails are required to repair broken bones and work for a relatively short time, just long enough to allow bone healing. Since orthopedic implants must perform under different operating conditions in life, a good understanding of the basic requirements of orthopedic materials and the subsequent biological responses is crucial for the design and optimization of implants under the physiological conditions of the human body. Choosing the right materials for an orthopedic implant depends on the specific application. Metal alloys, ceramics, and polymers are commonly used in orthopedic implants. These materials have different physical, chemical, and biological properties that suit specific applications. Despite the success of traditional materials, new and better biomaterials are constantly being developed to meet the ever-increasing demand.
North America Orthopedic Implants (Including Dental Implants) Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers/Opportunities
- Rising Geriatric Population
With this increasing age comes a reciprocal increase in the number of elderly patients admitted in hospitals due to fatal traumatic injuries. The rising prevalence of musculoskeletal diseases increases the demand for diagnosis and treatment. With the growing population, the pressure on the healthcare system is rising. The increasing need for proper treatment proportionally surges the market of care, services, and technologies to prevent and treat musculoskeletal conditions such as sarcopenia, osteoporosis, osteopenia, and other musculoskeletal complications. The elderly population is more prone to these conditions leading to fragile bones and joints. In such patients, orthopedic implants are used to provide them with immediate and efficient benefits associated with their bodies.
Therefore, the market for North America orthopedic implants is expected to grow in the forecast period due to rising geriatric population.
- Increasing Risk of Osteoporosis and Osteoarthritis
Osteoporosis is a disease of bone that progresses due to less bone mineral density and bone mass or due to some variation in the quality or structure of bone. Osteoporosis could increase the risk of fractures leading to broken bones due to decreased bone strength. It is more observed in women as compared to men. The post-menstrual women often get bone fractures due to osteoporosis, as the disease is silent and typically shows no symptoms. Mostly older people are more prone to osteoporosis. Osteoarthritis is a joint disease or an inflammation of the joints and surrounding tissues.
The mobility of a person is affected when such conditions occur. Thus, the increased risks of these conditions directly enhance the demand for orthopedic implants required to treat the malformations due to such conditions. Therefore, the increasing risk of osteoporosis and osteoarthritis is expected to drive the growth of the North America orthopedic implants (including dental implants) market.
- Rising Healthcare Infrastructure
The expense of money used by a country on its healthcare and its growth rate over time is inclined by a wide variety of economic and social factors, including the financing arrangements and structure of the organization of the health system. In particular, there is a strong association between the complete income level and how much the population of that country spends on health care.
Growing healthcare expenditure is beneficial for further economic growth and healthcare sector growth. Increasing healthcare expenditure is primarily fruitful as it significantly affects the development and advancement of orthopedic implants. Hence, huge healthcare expenditure is expected to create an opportunity for the North America orthopedic implants market.
Restraints/Challenges
- High Cost Associated with Procedures Involving Orthopedic Implants Treatment
Modern technology-based orthopedic implants help align the various body parts, such as the spine, hand, hip, and ankle among others. The key factors that determine the cost of orthopedic implants include the medical institution or clinic finalized for the procedure, treatment area, complexity, and chosen specialist, among more. As the cost of innovative and advanced orthopedic implants such as spinal implants, dental implants, orthobiologics, among others, is high, the treatment cost proportionally escalates, due to which the high cost of orthopedic implants may hamper the demand for the market.
- Inadequate Reimbursement Coverage
For several years, reimbursement for all healthcare devices and services has been under downward pressure. Orthopedic implants also face a major roadblock in their growth due to the lack of reimbursement for these devices.
The increased application of orthopedic implants in conditions such as musculoskeletal conditions, osteoporosis, and osteoarthritis makes it crucial for healthcare. However, the high cost of such medical devices and the lack of proper reimbursement hampers the adoption rate of orthopedic implants. Thus, the inadequate reimbursement coverage is expected to restrain the growth of the North America orthopedic implants (including dental implants) market.
Post-COVID-19 Impact on North America Orthopedic Implants (Including Dental Implants) Market
The orthopedic implants (including dental implants) market has been badly affected by COVID-19. Hospital admissions were limited to non-essential treatment, and OandP clinics were temporarily closed during the pandemic. The implementation of social distancing, blocking the population, and limited access to clinics has greatly affected the market. The slowdown in patient flows and referrals also affected the market growth. However, the market will continue to grow in the post-pandemic period due to the relaxation of previously imposed restrictions.
Manufacturers are making various strategic decisions to bounce back post-COVID-19. The players are conducting multiple R&D activities and product launches, and strategic partnerships to improve the technology and test results involved in the orthopedic implants (including dental implants) market.
Recent Developments
- In October 2022, 3M healthcare collaborated with Thermo Fisher Scientific, which is an American supplier of scientific instrumentation, reagents and consumables, and software services company. The collaboration between 3M and Thermo Fisher has enabled manufacturers to get high titer, high cell-density cultures to improve harvesting and clarification and optimize manufacturing capacity, quality, and efficiency.
- In August 2022, DePuy Synthes introduced INHANCE Shoulder System, a completely integrated shoulder anthroplasty system. The design of the device incorporates a simple stemless first surgical technique that is in line with how physicians approach patient care. Additionally, it allows surgeons to seamlessly switch between stemless and stemmed implants during interventions. This has aided the business in diversifying its product offering.
North America Orthopedic Implants (Including Dental Implants) Market Scope
The North America orthopedic implants (including dental implants) market is segmented into product type, biomaterial, procedure, fixation type, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
Product Type
- Reconstructive joint replacements
- Spinal implants
- Motion preservation devices/non-fusion devices
- Dental implants
- Trauma implants
- Orthobiologics
- Others
On the basis of product type, the North America orthopedic implants (including dental implants) market is segmented into reconstructive joint replacements, spinal implants, motion preservation devices/ non-fusion devices, dental implants, trauma implants, orthobiologics, and others.
Biomaterial
- Metallic biomaterials
- Ceramic biomaterials
- Polymeric biomaterials
- Natural biomaterials
- Others
On the basis of biomaterial, the North America orthopedic implants (including dental implants) market is segmented into metallic biomaterials, ceramic biomaterials, polymeric biomaterials, natural biomaterials, and others.
Procedure
- Open surgery
- Minimally invasive surgery (MIS)
On the basis of procedures, the North America orthopedic implants (including dental implants) market is segmented into open surgery and minimally invasive surgery (MIS).
Fixation Type
- Cement orthopedic implants
- Cementless orthopedic implants
- Hybrid orthopedic implants
On the basis of fixation type, the North America orthopedic implants (including dental implants) market is segmented into cement orthopedic implants, cementless orthopedic implants, and hybrid orthopedic implants.
End user
- Hospitals
- Ambulatory surgical centers
- Home care settings
- Academic & research institutes
- Others
On the basis of end user, the North America orthopedic implants (including dental implants) market is segmented into hospitals, clinics, ambulatory surgical centers, home care settings, academic and research institutes, and others.
Distribution channel
- Direct tender
- Retail sales
- Others
On the basis of distribution channel, the North America orthopedic implants (including dental implants) market is segmented into direct tender, retail sales, and others.
North America Orthopedic Implants (Including Dental Implants) Market Regional Analysis/Insights
北米の整形外科用インプラント（歯科用インプラントを含む）市場が分析され、製品タイプ、生体材料、手順、固定タイプ、エンドユーザー、流通チャネル別に市場規模の情報が提供されます。
この市場レポートでカバーされている国は、米国、カナダ、メキシコです。
- 2023年には、GDPが高く最大の消費者市場に主要な市場プレーヤーが存在するため、米国が市場を支配すると予想されます。
レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える国内市場における個別の市場影響要因と規制の変更も提供しています。新規販売、交換販売、国の人口統計、規制行為、輸出入関税などのデータ ポイントは、各国の市場シナリオを予測するために使用される主要な指標の一部です。また、国別データの予測分析を提供する際には、北米ブランドの存在と可用性、地元および国内ブランドとの競争が激しいか少ないために直面する課題、販売チャネルの影響も考慮されます。
競争環境と北米整形外科インプラント（歯科インプラントを含む）市場シェア分析
北米整形外科インプラント（歯科インプラントを含む）市場の競争状況は、競合他社ごとに詳細を提供します。含まれる詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、生産拠点と施設、会社の強みと弱み、製品の発売、製品試験パイプライン、製品の承認、特許、製品の幅と幅、アプリケーションの優位性、技術ライフライン曲線などがあります。提供されている上記のデータ ポイントは、北米整形外科インプラント（歯科インプラントを含む）への会社の重点にのみ関連しています。
北米の整形外科用インプラント（歯科インプラントを含む）市場で事業を展開している主要企業には、DePuy Synthes（Johnson & Johnson Inc. の子会社）、Zimmer Biomet、Smith & Nephew plc、Medtronic、Stryker、B. Braun Melsungen AG、Changzhou Waston Medical Appliance Co., Ltd.、Integra LifeSciences、Narang Medical Limited、WL Gore & Associates、Inc.、3M、Arthrex、Inc.、General Electric Company、DJO、LLC（Colfax Corporation の子会社）、Samay Surgical、BioHorizons、Envista、Egifix、Institut Straumann AG、Canwell Medical Co., Ltd.、Corin Group、Globus Medical、CONMED Corporation、Bonetech Medisys PVT LTD.、EgiFix Medical などがあります。
SKU-
世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする
- インタラクティブなデータ分析ダッシュボード
- 成長の可能性が高い機会のための企業分析ダッシュボード
- カスタマイズとクエリのためのリサーチアナリストアクセス
- インタラクティブなダッシュボードによる競合分析
- 最新ニュース、更新情報、トレンド分析
- 包括的な競合追跡のためのベンチマーク分析のパワーを活用
目次
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 PRODUCT TYPE LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES
5 EPIDERMIOLOGY
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING GERIATRIC POPULATION
6.1.2 INCREASING RISK OF OSTEOPOROSIS AND OSTEOARTHRITIS
6.1.3 TECHNOLOGICAL ADVANCEMENT IN ORTHOPEDIC IMPLANTS
6.1.4 RISING AWARENESS ABOUT ORTHOPEDIC IMPLANT
6.2 RESTRAINTS
6.2.1 HIGH COST ASSOCIATED WITH PROCEDURES INVOLVING ORTHOPEDIC IMPLANTS TREATMENT
6.2.2 PRODUCT RECALL
6.3 OPPORTUNITIES
6.3.1 RISING HEALTHCARE INFRASTRUCTURE
6.3.2 INCREASE IN DEMAND FOR MINIMALLY INVASIVE PROCEDURES
6.3.3 INCREASING NUMBER OF JOINT REPLACEMENTS AND SPORTS ACCIDENT
6.3.4 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS
6.4 CHALLENGES
6.4.1 INADEQUATE REIMBURSEMENT COVERAGE
6.4.2 STRINGENT GOVERNMENT POLICIES FOR APPROVAL OF ORTHOPEDIC IMPLANTS
6.4.3 SIDE-EFFECTS OF ORTHOPEDIC IMPLANTS
7 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 RECONSTRUCTIVE JOINT REPLACEMENTS
7.2.1 KNEE REPLACEMENT IMPLANTS
7.2.1.1 TOTAL KNEE REPLACEMENT
7.2.1.1.1 FIXED BEARING IMPLANTS
7.2.1.1.2 MOBILE BEARING IMPLANTS
7.2.1.1.3 OTHERS
7.2.1.2 PARTIAL KNEE REPLACEMENT
7.2.1.2.1 FIXED BEARING IMPLANTS
7.2.1.2.2 MOBILE BEARING IMPLANTS
7.2.1.2.3 OTHERS
7.2.1.3 REVISION KNEE REPLACEMENT
7.2.1.3.1 FIXED BEARING IMPLANTS
7.2.1.3.2 MOBILE BEARING IMPLANTS
7.2.1.3.3 OTHERS
7.2.1.4 OTHERS
7.2.2 HIP REPLACEMENT IMPLANTS
7.2.2.1 TOTAL HIP REPLACEMENT IMPLANTS
7.2.2.2 PARTIAL HIP REPLACEMENT IMPLANTS
7.2.2.3 HIP SURFACING REPLACEMENT IMPLANTS
7.2.2.4 REVISION REPLACEMENT IMPLANTS
7.2.3 EXTREMITIES
7.2.3.1 UPPER EXTREMITY RECONSTRUCTION
7.2.3.1.1 ELBOW IMPLANTS
7.2.3.1.2 SHOULDER IMPLANTS
7.2.3.1.3 HAND WRIST IMPLANTS
7.2.3.2 LOWER EXTREMITY RECONSTRUCTION
7.2.3.2.1 FOOT IMPLANTS
7.2.3.2.2 ANKLE IMPLANTS
7.2.3.2.3 OTHERS
7.3 SPINAL IMPLANTS
7.3.1 SPINAL FUSION IMPLANTS
7.3.1.1 THORACOLUMBAR DEVICES
7.3.1.2 CERVICAL FIXATION DEVICES
7.3.1.3 INTERBODY FUSION DEVICES
7.3.2 VERTEBRAL COMPRESSION FRACTURE (VCF) DEVICES
7.3.2.1 BALLOON KYPHOPLASTY DEVICES
7.3.2.2 VERTEBROPLASTY DEVICES
7.4 MOTION PRESERVATION DEVICES/NON-FUSION DEVICES
7.4.1 DYNAMIC STABILIZATION DEVICES
7.4.2 ARTIFICIAL DISC DISPLACEMENT DEVICES
7.4.3 ANNULUS REPAIR DEVICES
7.4.4 DENTAL IMPLANTS
7.4.5 NUCLEAR DISC PROSTHESES
7.5 DENTAL IMPLANTS
7.5.1 ENDOSTEAL IMPLANTS
7.5.2 SUBPERIOSTAL IMPLANTS
7.5.3 TRANSOSTEAL DEVICES
7.5.4 OTHERS
7.6 TRAUMA IMPLANTS
7.6.1 METAL PLATES AND SCREWS
7.6.2 PINS/WIRES
7.6.3 NAILS & RODS
7.6.4 OTHERS
7.7 ORTHOBIOLOGICS
7.7.1 DEMINERALIZED BONE MATRIX
7.7.2 ALLOGRAFT
7.7.3 BONE MORPHOGENETIC PROTEIN
7.7.4 VISCOSUPPLEMENTATION PRODUCT
7.7.5 SYNTHETIC BONE SUBSITUTES
7.7.6 STEM CELLS
7.7.7 OTHERS
7.8 OTHERS
8 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY BIOMATERIAL
8.1 OVERVIEW
8.2 METALLIC BIOMATERIALS
8.2.1 STAINLESS STEEL
8.2.2 TITANIUM ALLOY
8.2.3 COBALT ALLOY
8.2.4 ZIRCONIUM
8.2.5 CHROMIUM
8.2.6 MOLYBDENUM
8.2.7 OTHERS
8.3 POLYMERIC BIOMATERIALS
8.4 CERAMIC BIOMATERIALS
8.5 NATURAL BIOMATERIALS
8.6 OTHERS
9 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PROCEDURE
9.1 OVERVIEW
9.2 OPEN SURGERY
9.2.1 INTERNAL FIXATION DEVICES
9.2.2 EXTERNAL FIXATION DEVICES
9.3 MINIMALLY INVASIVE SURGERY (MIS)
9.3.1 INTERNAL FIXATION DEVICES
9.3.2 EXTERNAL FIXATION DEVICES
9.4 OTHERS
10 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY FIXATION TYPE
10.1 OVERVIEW
10.2 CEMENT ORTHOPEDIC IMPLANTS
10.2.1 RECONSTRUCTIVE JOINT REPLACEMENTS
10.2.2 SPINAL IMPLANTS
10.2.3 MOTION PRESERVATION DEVICES/ NON-FUSION DEVICES
10.2.4 DENTAL IMPLANTS
10.2.5 TRAUMA IMPLANTS
10.2.6 ORTHOBIOLOGICS
10.2.7 OTHERS
10.3 CEMENTLESS ORTHOPEDIC IMPLANTS
10.3.1 RECONSTRUCTIVE JOINT REPLACEMENTS
10.3.2 SPINAL IMPLANTS
10.3.3 MOTION PRESERVATION DEVICES/ NON-FUSION DEVICES
10.3.4 DENTAL IMPLANTS
10.3.5 TRAUMA IMPLANTS
10.3.6 ORTHOBIOLOGICS
10.3.7 OTHERS
10.4 HYBRID ORTHOPEDIC IMPLANTS
10.4.1 RECONSTRUCTIVE JOINT REPLACEMENTS
10.4.2 SPINAL IMPLANTS
10.4.3 MOTION PRESERVATION DEVICES/ NON-FUSION DEVICES
10.4.4 DENTAL IMPLANTS
10.4.5 TRAUMA IMPLANTS
10.4.6 ORTHOBIOLOGICS
10.4.7 OTHERS
11 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITALS
11.3 CLINICS
11.3.1 ORTHOPEDIC CLINICS
11.3.2 DENTAL CLINICS
11.3.3 OTHERS
11.4 AMBULATORY CARE CENTER
11.5 HOME CARE SETTINGS
11.6 ACADEMIC AND RESEARCH INSTITUTES
11.7 OTHERS
12 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 DIRECT TENDER
12.3 RETAIL SALES
12.4 OTHERS
13 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY REGION
13.1 NORTH AMERICA
13.1.1 U.S.
13.1.2 CANADA
13.1.3 MEXICO
14 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET
14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 MEDTRONIC
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENTS
16.2 DEPUY SYNTHES (A SUBSIDIARY OF JOHNSON & JOHNSON INC.)
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENTS
16.3 ZIMMER BIOMET
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENTS
16.4 SMITH & NEPHEW PLC
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 PRODUCT PORTFOLIO
16.4.5 RECENT DEVELOPMENTS
16.5 3M
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 PRODUCT PORTFOLIO
16.5.5 RECENT DEVELOPMENT
16.6 DJO, LLC (A SUBSIDIARY OF COLFAX CORPORATION)
16.6.1 COMPANY SNAPSHOT
16.6.2 REVENUE ANALYSIS
16.6.3 PRODUCT PORTFOLIO
16.6.4 RECENT DEVELOPMENTS
16.7 ARTHREX, INC.
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENTS
16.8 B. BRAUN MELSENGEN AG
16.8.1 COMPANY SNAPSHOT
16.8.2 REVENUE ANALYSIS
16.8.3 PRODUCT PORTFOLIO
16.8.4 RECENT DEVELOPMENTS
16.9 BIOHORIZONS
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENT
16.1 BONETECH MEDISYS P.V.T LTD.
16.10.1 COMPANY SNAPSHOT
16.10.2 PRODUCT PORTFOLIO
16.10.3 RECENT DEVELOPMENT
16.11 CANWELL MEDICAL CO, LTD.
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENTS
16.12 CONMED CORPORATION
16.12.1 COMPANY SNAPSHOT
16.12.2 REVENUE ANALYSIS
16.12.3 PRODUCT PORTFOLIO
16.12.4 RECENT DEVELOPMENTS
16.13 CORIN GROUP
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENTS
16.14 CUREX
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENT
16.15 EGIFIX MEDICAL
16.15.1 COMPANY SNAPSHOT
16.15.2 PRODUCT PORTFOLIO
16.15.3 RECENT DEVELOPMENT
16.16 ENVISTA
16.16.1 COMPANY SNAPSHOT
16.16.2 REVENUE ANALYSIS
16.16.3 PRODUCT PORTFOLIO
16.16.4 RECENT DEVELOPMENTS
16.17 GENERAL ELECTRIC COMPANY
16.17.1 COMPANY SNAPSHOT
16.17.2 REVENUE ANALYSIS
16.17.3 PRODUCT PORTFOLIO
16.17.4 RECENT DEVELOPMENTS
16.18 GLOBUS MEDICAL
16.18.1 COMPANY SNAPSHOT
16.18.2 REVENUE ANALYSIS
16.18.3 PRODUCT PORTFOLIO
16.18.4 RECENT DEVELOPMENTS
16.19 INSTITUT STRAUMANN AG
16.19.1 COMPANY SNAPSHOT
16.19.2 REVENUE ANALYSIS
16.19.3 PRODUCT PORTFOLIO
16.19.4 RECENT DEVELOPMENTS
16.2 INTEGRA LIFESCIENCES
16.20.1 COMPANY SNAPSHOT
16.20.2 REVENUE ANALYSIS
16.20.3 PRODUCT PORTFOLIO
16.20.4 RECENT DEVELOPMENTS
16.21 NARANG MEDICAL LIMITED
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENT
16.22 SAMAY SURGICAL
16.22.1 COMPANY SNAPSHOT
16.22.2 PRODUCT PORTFOLIO
16.22.3 RECENT DEVELOPMENT
16.23 STRYKER
16.23.1 COMPANY SNAPSHOT
16.23.2 REVENUE ANALYSIS
16.23.3 PRODUCT PORTFOLIO
16.23.4 RECENT DEVELOPMENTS
16.24 CHANGZHOU WASTON MEDICAL APPLIANCES CO., LTD.
16.24.1 COMPANY SNAPSHOT
16.24.2 PRODUCT PORTFOLIO
16.24.3 RECENT DEVELOPMENT
16.25 W. L. GORE & ASSOCIATES, INC.
16.25.1 COMPANY SNAPSHOT
16.25.2 PRODUCT PORTFOLIO
16.25.3 RECENT DEVELOPMENTS
17 QUESTIONNAIRE
18 RELATED REPORTS
表のリスト
TABLE 1 COST OF HIP REPLACEMENT SHOWN BY VARIOUS COUNTRIES
TABLE 1 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 2 NORTH AMERICA RECONSTRUCTIVE JOINT REPLACEMENTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 3 NORTH AMERICA RECONSTRUCTIVE JOINT REPLACEMENTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 4 NORTH AMERICA KNEE REPLACEMENT IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 5 NORTH AMERICA TOTAL KNEE REPLACEMENT IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 6 NORTH AMERICA PARTIAL KNEE REPLACEMENT IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 7 NORTH AMERICA REVISION KNEE REPLACEMENT IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 8 NORTH AMERICA HIP REPLACEMENT IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 9 NORTH AMERICA EXTREMITIES IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 10 NORTH AMERICA UPPER EXTREMITY RECONSTRUCTION IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 11 NORTH AMERICA LOWER EXTREMITY RECONSTRUCTION IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 12 NORTH AMERICA SPINAL IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 13 NORTH AMERICA SPINAL IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 14 NORTH AMERICA SPINAL FUSION IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 15 NORTH AMERICA VERTEBRAL COMPRESSION FRACTURE (VCF) DEVICES IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 16 NORTH AMERICA MOTION PRESERVATION DEVICES/NON-FUSION DEVICES IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 17 NORTH AMERICA MOTION PRESERVATION DEVICES/NON-FUSION DEVICES IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 18 NORTH AMERICA DENTAL IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 19 NORTH AMERICA DENTAL IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 20 NORTH AMERICA TRAUMA IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 21 NORTH AMERICA TRAUMA IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 22 NORTH AMERICA ORTHOBIOLOGICS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 23 NORTH AMERICA ORTHOBIOLOGICS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 24 NORTH AMERICA OTHERS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 25 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY BIOMATERIAL, 2021-2030 (USD MILLION)
TABLE 26 NORTH AMERICA METALLIC BIOMATERIALS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 27 NORTH AMERICA METALLIC BIOMATERIALS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY BIOPOLYMER TYPE, 2021-2030 (USD MILLION)
TABLE 28 NORTH AMERICA POLYMERIC BIOMATERIALS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 29 NORTH AMERICA CERAMIC BIOMATERIALS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 30 NORTH AMERICA NATURAL BIOMATERIALS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 31 NORTH AMERICA OTHERS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 32 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 33 NORTH AMERICA OPEN SURGERY IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 34 NORTH AMERICA OPEN SURGERY IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 35 NORTH AMERICA MINIMALLY INVASIVE SURGERY (MIS) IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 36 NORTH AMERICA MINIMALLY INVASIVE SURGERY (MIS) IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 37 NORTH AMERICA OTHERS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 38 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY FIXATION TYPE, 2021-2030 (USD MILLION)
TABLE 39 NORTH AMERICA CEMENT ORTHOPEDIC IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 40 NORTH AMERICA CEMENT ORTHOPEDIC IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY FIXATION TYPE, 2021-2030 (USD MILLION)
TABLE 41 NORTH AMERICA CEMENTLESS ORTHOPEDIC IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 42 NORTH AMERICA CEMENTLESS ORTHOPEDIC IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY FIXATION TYPE, 2021-2030 (USD MILLION)
TABLE 43 NORTH AMERICA HYBRID ORTHOPEDIC IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 44 NORTH AMERICA HYBRID ORTHOPEDIC IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY FIXATION TYPE, 2021-2030 (USD MILLION)
TABLE 45 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 46 NORTH AMERICA HOSPITALS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 47 NORTH AMERICA CLINICS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 48 NORTH AMERICA CLINICS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 49 NORTH AMERICA AMBULATORY CARE CENTER IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 50 NORTH AMERICA HOME CARE SETTINGS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 51 NORTH AMERICA ACADEMIC AND RESEARCH INSTITUTES IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 52 NORTH AMERICA OTHERS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 53 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 54 NORTH AMERICA DIRECT TENDER IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 55 NORTH AMERICA RETAIL SALES IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 56 NORTH AMERICA OTHERS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 57 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 58 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 59 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 60 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 ASP
TABLE 61 NORTH AMERICA RECONSTRUCTIVE JOINT REPLACEMENTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 62 NORTH AMERICA KNEE REPLACEMENT IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 63 NORTH AMERICA TOTAL KNEE REPLACEMENT IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 64 NORTH AMERICA PARTIAL KNEE REPLACEMENT IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 65 NORTH AMERICA REVISION KNEE REPLACEMENT IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 66 NORTH AMERICA HIP REPLACEMENT IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 67 NORTH AMERICA EXTREMITIES IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 68 NORTH AMERICA UPPER EXTREMITY RECONSTRUCTION IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 69 NORTH AMERICA LOWER EXTREMITY RECONSTRUCTION IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 70 NORTH AMERICA SPINAL IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 71 NORTH AMERICA SPINAL FUSION IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 72 NORTH AMERICA VERTEBRAL COMPRESSION FRACTURE (VCF) DEVICES IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 73 NORTH AMERICA MOTION PRESERVATION DEVICES/NON-FUSION DEVICES IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 74 NORTH AMERICA DENTAL IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 75 NORTH AMERICA TRAUMA IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 76 NORTH AMERICA ORTHOBIOLOGICS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 77 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY BIOMATERIAL, 2021-2030 (USD MILLION)
TABLE 78 NORTH AMERICA METALLIC BIOMATERIALS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY BIOMATERIAL, 2021-2030 (USD MILLION)
TABLE 79 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PROCEDURES, 2021-2030 (USD MILLION)
TABLE 80 NORTH AMERICA OPEN SURGERY IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PROCEDURES, 2021-2030 (USD MILLION)
TABLE 81 NORTH AMERICA MINIMALLY INVASIVE SURGERY (MIS) IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PROCEDURES, 2021-2030 (USD MILLION)
TABLE 82 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY FIXATION TYPE, 2021-2030 (USD MILLION)
TABLE 83 NORTH AMERICA CEMENT ORTHOPEDIC IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 84 NORTH AMERICA CEMENTLESS ORTHOPEDIC IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 85 NORTH AMERICA HYBRID ORTHOPEDIC IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 86 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 87 NORTH AMERICA CLINICS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 88 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 89 U.S. ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 90 U.S. ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 91 U.S. ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 ASP
TABLE 92 U.S. RECONSTRUCTIVE JOINT REPLACEMENTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 93 U.S. KNEE REPLACEMENT IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 94 U.S. TOTAL KNEE REPLACEMENT IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 95 U.S. PARTIAL KNEE REPLACEMENT IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 96 U.S. REVISION KNEE REPLACEMENT IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 97 U.S. HIP REPLACEMENT IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 98 U.S. EXTREMITIES IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 99 U.S. UPPER EXTREMITY RECONSTRUCTION IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 100 U.S. LOWER EXTREMITY RECONSTRUCTION IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 101 U.S. SPINAL IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 102 U.S. SPINAL FUSION IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 103 U.S. VERTEBRAL COMPRESSION FRACTURE (VCF) DEVICES IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 104 U.S. MOTION PRESERVATION DEVICES/NON-FUSION DEVICES IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 105 U.S. DENTAL IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 106 U.S. TRAUMA IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 107 U.S. ORTHOBIOLOGICS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 108 U.S. ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY BIOMATERIAL, 2021-2030 (USD MILLION)
TABLE 109 U.S. METALLIC BIOMATERIALS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY BIOMATERIAL, 2021-2030 (USD MILLION)
TABLE 110 U.S. ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PROCEDURES, 2021-2030 (USD MILLION)
TABLE 111 U.S. OPEN SURGERY IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PROCEDURES, 2021-2030 (USD MILLION)
TABLE 112 U.S. MINIMALLY INVASIVE SURGERY (MIS) IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PROCEDURES, 2021-2030 (USD MILLION)
TABLE 113 U.S. ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY FIXATION TYPE, 2021-2030 (USD MILLION)
TABLE 114 U.S. CEMENT ORTHOPEDIC IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 115 U.S. CEMENTLESS ORTHOPEDIC IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 116 U.S. HYBRID ORTHOPEDIC IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 117 U.S. ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 118 U.S. CLINICS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 119 U.S. ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 120 CANADA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 121 CANADA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 122 CANADA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 ASP
TABLE 123 CANADA RECONSTRUCTIVE JOINT REPLACEMENTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 124 CANADA KNEE REPLACEMENT IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 125 CANADA TOTAL KNEE REPLACEMENT IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 126 CANADA PARTIAL KNEE REPLACEMENT IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 127 CANADA REVISION KNEE REPLACEMENT IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 128 CANADA HIP REPLACEMENT IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 129 CANADA EXTREMITIES IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 130 CANADA UPPER EXTREMITY RECONSTRUCTION IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 131 CANADA LOWER EXTREMITY RECONSTRUCTION IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 132 CANADA SPINAL IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 133 CANADA SPINAL FUSION IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 134 CANADA VERTEBRAL COMPRESSION FRACTURE (VCF) DEVICES IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 135 CANADA MOTION PRESERVATION DEVICES/NON-FUSION DEVICES IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 136 CANADA TRAUMA IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 137 CANADA ORTHOBIOLOGICS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 138 CANADA METALLIC BIOMATERIALS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY BIOMATERIAL, 2021-2030 (USD MILLION)
TABLE 139 CANADA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PROCEDURES, 2021-2030 (USD MILLION)
TABLE 140 CANADA OPEN SURGERY IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PROCEDURES, 2021-2030 (USD MILLION)
TABLE 141 CANADA MINIMALLY INVASIVE SURGERY (MIS) IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PROCEDURES, 2021-2030 (USD MILLION)
TABLE 142 CANADA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY FIXATION TYPE, 2021-2030 (USD MILLION)
TABLE 143 CANADA CEMENT ORTHOPEDIC IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 144 CANADA CEMENTLESS ORTHOPEDIC IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 145 CANADA HYBRID ORTHOPEDIC IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 146 CANADA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 147 CANADA CLINICS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 148 CANADA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 149 MEXICO ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 150 MEXICO ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 151 MEXICO ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 ASP
TABLE 152 MEXICO RECONSTRUCTIVE JOINT REPLACEMENTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 153 MEXICO KNEE REPLACEMENT IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION
TABLE 154 MEXICO PARTIAL KNEE REPLACEMENT IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 155 MEXICO REVISION KNEE REPLACEMENT IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 156 MEXICO HIP REPLACEMENT IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 157 MEXICO EXTREMITIES IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 158 MEXICO UPPER EXTREMITY RECONSTRUCTION IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 159 MEXICO LOWER EXTREMITY RECONSTRUCTION IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 160 MEXICO SPINAL IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 161 MEXICO SPINAL FUSION IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 162 MEXICO VERTEBRAL COMPRESSION FRACTURE (VCF) DEVICES IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 163 MEXICO MOTION PRESERVATION DEVICES/NON-FUSION DEVICES IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 164 MEXICO DENTAL IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 165 MEXICO TRAUMA IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 166 MEXICO ORTHOBIOLOGICS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 167 MEXICO ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY BIOMATERIAL, 2021-2030 (USD MILLION)
TABLE 168 MEXICO METALLIC BIOMATERIALS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY BIOMATERIAL, 2021-2030 (USD MILLION)
TABLE 169 MEXICO ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PROCEDURES, 2021-2030 (USD MILLION)
TABLE 170 MEXICO OPEN SURGERY IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PROCEDURES, 2021-2030 (USD MILLION)
TABLE 171 MEXICO MINIMALLY INVASIVE SURGERY (MIS) IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PROCEDURES, 2021-2030 (USD MILLION)
TABLE 172 MEXICO ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY FIXATION TYPE, 2021-2030 (USD MILLION)
TABLE 173 MEXICO CEMENT ORTHOPEDIC IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 174 MEXICO CEMENTLESS ORTHOPEDIC IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 175 MEXICO HYBRID ORTHOPEDIC IMPLANTS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 176 MEXICO ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 177 MEXICO CLINICS IN ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 178 MEXICO ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
図表一覧
FIGURE 1 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET: SEGMENTATION
FIGURE 11 INCREASING USE OF ORTHOPEDIC IMPLANTS IS EXPECTED TO DRIVE THE NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET GROWTH IN THE FORECAST PERIOD
FIGURE 12 RECONSTRUCTIVE JOINT REPLACEMENTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET IN 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET
FIGURE 14 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET : BY PRODUCT TYPE, 2022
FIGURE 15 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET : BY PRODUCT TYPE, 2023-2030 (USD MILLION)
FIGURE 16 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET : BY PRODUCT TYPE, CAGR (2023-2030)
FIGURE 17 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET : BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 18 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET: BY BIOMATERIAL, 2022
FIGURE 19 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET: BY BIOMATERIAL, 2023-2030 (USD MILLION)
FIGURE 20 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET: BY BIOMATERIAL, CAGR (2023-2030)
FIGURE 21 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET: BY BIOMATERIAL, LIFELINE CURVE
FIGURE 22 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET: BY PROCEDURE, 2022
FIGURE 23 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET: BY PROCEDURE, 2023-2030 (USD MILLION)
FIGURE 24 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET: BY PROCEDURE, CAGR (2023-2030)
FIGURE 25 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET: BY PROCEDURE, LIFELINE CURVE
FIGURE 26 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET: BY FIXATION TYPE, 2022
FIGURE 27 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET: BY FIXATION TYPE, 2023-2030 (USD MILLION)
FIGURE 28 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET: BY FIXATION TYPE, CAGR (2023-2030)
FIGURE 29 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET: BY FIXATION TYPE, LIFELINE CURVE
FIGURE 30 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET: BY END USER, 2022
FIGURE 31 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 32 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET: BY END USER, CAGR (2023-2030)
FIGURE 33 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET: BY END USER, LIFELINE CURVE
FIGURE 34 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 35 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 36 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 37 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 38 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET: SNAPSHOT (2022)
FIGURE 39 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET: BY COUNTRY (2022)
FIGURE 40 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET: BY COUNTRY (2023 & 2030)
FIGURE 41 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET: BY COUNTRY (2022 & 2030)
FIGURE 42 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET: BY PRODUCT TYPE (2023-2030)
FIGURE 43 NORTH AMERICA ORTHOPEDIC IMPLANTS (INCLUDING DENTAL IMPLANTS) MARKET: COMPAY SHARE 2021 (%)
調査方法
データ収集と基準年分析は、大規模なサンプル サイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。
DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。
カスタマイズ可能
Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。
